Labetuzumab govitecan (IMMU-130) is an antibody–drug conjugate (ADC) that was investigated for the treatment of colorectal cancer. Labetuzumab has also been evaluated in patients with metastatic medullary thyroid carcinoma (MTC).
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.